Malmsten M - Search Results

1

Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients.

Rodríguez M, Ringstad L, Schäfer P, Just S, Hofer HW, Malmsten M, Siegel G. Rodríguez M, et al. Among authors: malmsten m. Atherosclerosis. 2007 Jun;192(2):438-44. doi: 10.1016/j.atherosclerosis.2007.02.021. Epub 2007 Mar 29. Atherosclerosis. 2007. PMID: 17397850

2

Lipoprotein binding to anionic biopolyelectrolytes and the effect of glucose on nanoplaque formation in arteriosclerosis and Alzheimer's disease.

Siegel G, Mockenhaupt FHME, Behnke AL, Ermilov E, Winkler K, Pries AR, Malmsten M, Hetzer R, Saunders R, Lindman B. Siegel G, et al. Among authors: malmsten m. Adv Colloid Interface Sci. 2016 Jun;232:25-35. doi: 10.1016/j.cis.2016.02.001. Epub 2016 Feb 19. Adv Colloid Interface Sci. 2016. PMID: 26969281 Review.

3

Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis.

Siegel G, Schäfer P, Winkler K, Malmsten M. Siegel G, et al. Among authors: malmsten m. Wien Med Wochenschr. 2007;157(13-14):288-94. doi: 10.1007/s10354-007-0426-6. Wien Med Wochenschr. 2007. PMID: 17704974

4

Reduction of arteriosclerotic nanoplaque formation and size by n-3 fatty acids in patients after valvular defect operation.

Koppe C, Rodríguez M, Winkler K, Pietzsch J, Neumann K, Hiemann NE, Hetzer R, Malmsten M, Siegel G. Koppe C, et al. Among authors: malmsten m. Forsch Komplementmed. 2009 Aug;16(4):237-45. doi: 10.1159/000229786. Epub 2009 Aug 13. Forsch Komplementmed. 2009. PMID: 19729934

5

Towards biosensing of arteriosclerotic nanoplaque formation using femtosecond spectroscopy.

Rodríguez M, Lindinger A, Ernsting NP, Malmsten M, Siegel G. Rodríguez M, et al. Among authors: malmsten m. Arch Biochem Biophys. 2007 Apr 1;460(1):92-9. doi: 10.1016/j.abb.2007.01.018. Epub 2007 Feb 5. Arch Biochem Biophys. 2007. PMID: 17324375

6

The effect of garlic on arteriosclerotic nanoplaque formation and size.

Siegel G, Malmsten M, Pietzsch J, Schmidt A, Buddecke E, Michel F, Ploch M, Schneider W. Siegel G, et al. Among authors: malmsten m. Phytomedicine. 2004 Jan;11(1):24-35. doi: 10.1078/0944-7113-00377. Phytomedicine. 2004. PMID: 14971718

7

Reduction of arteriosclerotic nanoplaque formation and size by fluvastatin in a receptor-based biosensor model.

Siegel G, Abletshauser C, Malmsten M, Schmidt A, Winkler K. Siegel G, et al. Among authors: malmsten m. Cardiovasc Res. 2003 Jun 1;58(3):696-705. doi: 10.1016/s0008-6363(03)00249-9. Cardiovasc Res. 2003. PMID: 12798444

8

The effect of an HMG-CoA reductase inhibitor on arteriosclerotic nanoplaque formation and size in a biosensor model.

Siegel G, Abletshauser C, Malmsten M, Klüssendorf D. Siegel G, et al. Among authors: malmsten m. Biosens Bioelectron. 2003 May;18(5-6):635-47. doi: 10.1016/s0956-5663(03)00034-4. Biosens Bioelectron. 2003. PMID: 12706573

9

Biosensing of arteriosclerotic nanoplaque formation and interaction with an HMG-CoA reductase inhibitor.

Abletshauser C, Klüssendorf D, Schmidt A, Winkler K, März W, Buddecke E, Malmsten M, Siegel G. Abletshauser C, et al. Among authors: malmsten m. Acta Physiol Scand. 2002 Oct;176(2):131-45. doi: 10.1046/j.1365-201X.2002.01020.x. Acta Physiol Scand. 2002. PMID: 12354173

10

Physicochemical binding properties of the proteoglycan receptor for serum lipoproteins.

Siegel G, Malmsten M, Klüssendorf D, Leonhardt W. Siegel G, et al. Among authors: malmsten m. Atherosclerosis. 1999 May;144(1):59-67. doi: 10.1016/s0021-9150(99)00042-8. Atherosclerosis. 1999. PMID: 10381278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results